PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

Summary

This study will advance the investigator's knowledge of the integrated cardiorenal and humoral physiology in type 2 diabetic patients with and without pre-clinical diastolic dysfunction, and test a novel therapeutic strategy which may prevent a progression to symptomatic Stage C heart failure

Timeline

Start

2018-05-01

Primary completion

2025-08-27

Completion

2025-08-27

Drugs

Indications